Schlieren, Switzerland

Laura Codarri Deak

USPTO Granted Patents = 5 

 

Average Co-Inventor Count = 4.5

ph-index = 2

Forward Citations = 11(Granted Patents)


Company Filing History:


Years Active: 2022-2024

Loading Chart...
Loading Chart...
5 patents (USPTO):

Title: Laura Codarri Deak: Innovator in Cancer Therapeutics

Introduction

Laura Codarri Deak is a prominent inventor based in Schlieren, Switzerland. She has made significant contributions to the field of cancer research, particularly in developing therapeutic and diagnostic methods. With a total of 5 patents to her name, her work focuses on enhancing immune function in individuals suffering from cancer.

Latest Patents

Among her latest patents, one notable invention is related to therapeutic and diagnostic methods for cancer. This invention provides methods of treatment and ways to determine whether an individual suffering from cancer is responding to treatment involving a PD-1 axis binding antagonist. Additionally, it predicts the responsiveness of individuals to such treatments and offers methods for selecting appropriate therapies. Another significant patent involves immunoconjugates, specifically those comprising a mutant interleukin-2 polypeptide and an antibody that binds to PD-1. This invention also includes polynucleotide molecules encoding the immunoconjugates, as well as methods for producing these mutant immunoconjugates and their pharmaceutical compositions.

Career Highlights

Laura has worked with notable companies in the pharmaceutical industry, including Hoffmann-La Roche Inc. and F. Hoffmann-La Roche AG. Her experience in these organizations has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Throughout her career, Laura has collaborated with esteemed colleagues such as Christian Klein and Stefan Seeber. These partnerships have further enriched her research and innovation in cancer therapeutics.

Conclusion

Laura Codarri Deak stands out as a dedicated inventor whose work in cancer therapeutics has the potential to significantly impact patient care. Her innovative approaches and collaborations highlight her commitment to advancing medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…